Fuze Health

Fuze Health

Private
New York City, New YorkHealthcare & Life Scienceshttps://fuzehealth.com/

Last Round

Series D

Extension

9/8/2022

Total Funding Raised

$541.8M

Momentum Score

100 /100

Company Overview

Fuze Health is a healthcare technology company that provides an integrated platform for personalized home healthcare, including diagnostics, virtual care, and pharmacy services.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Telemedicine, Patient Engagement, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital pharmacyat-home testingat-home diagnosticsintegrated healthcare platformpharmacy APItelehealth platformprescription fulfillmentmail-order pharmacyvirtual pharmacymedication managementprescription home deliveryfertility pharmacyB2B healthcare platformdirect-to-patient pharmacywomen's healthat-home genomicspharma supply chainvalue-based care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fuze Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fuze Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series D Extension9/8/2022
Series D10/27/2021
Series D6/8/2021
Series C9/9/2020
Series B7/8/2020
Series C
5/6/2020

Key People

Founding team and executive leadership

Oonagh O'Brien

CEO, Fuze Services, Product Strategy, Fuze Technologies

Executive Team

Paul Greenall

CEO, FuzeRx And Chief Development Officer, Fuze Health

Executive Team

Amer Waheed

Chief Technology Officer, FuzeRx

Executive Team

Mike Tesar

Chief Technology Officer

Executive Team

Fuze Health Investors

Notable investors and investment history

InvestorRounds
Slow VenturesSeed
Deerfield ManagementSeries C
TI Platform FundSeries B
Transpose Platform ManagementSeries C, Series D
Oak HC/FTSeries C
Tuesday CapitalSeries A
Optum VenturesSeries C, Series B, Series D, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2026

    Grew 21% QoQ, from 99 to 120 employees.

  • Apr 20, 2026

    Monthly visitors increased 139% MoM, reaching 60.6K.

Fuze Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fuze Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fuze Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range120
Year Founded2024
Last Funding9/8/2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.